Clinical Trials Directory

Trials / Terminated

TerminatedNCT00880529

Pain Relief for Ventilated Patients With Multiple Rib Fractures Using the ON-Q Pain Relief System

Does Continuous Subcutaneous Paravertebral Infusion of Bupivicaine With the ON-Q Pain Relief System vs. Standard IV Pain Management Decrease Ventilator Dependence in Trauma Patients With Multiple Rib Fractures

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
2 (actual)
Sponsor
The Cooper Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out if patients having the ON-Q post-op Pain Relief System for pain management of multiple rib fractures will require fewer ventilator days, and will need less IV pain medicine to control their pain, and as a result have improved respiratory function during their recovery. The standard of care for providing pain relief for rib fractures is to use an opioid drug that is injected into the vein but also has side effects. Increased doses can lead to over sedation and consequently lead to difficulty with breathing. The ON-Q pain relief systems uses a local anesthetic under the skin. The anesthetic is called bupivicaine, and it is delivered from a thin tube approximately 10 inches long is tunneled under the skin along the back and parallel to the spine. The medication is stored in an elastic pump which delivers a slow continuous drip of medication from multiple holes in the tubing. Subjects will be randomized to either standard intravenous opioid pain management or the ON-Q pain relief device with supplemental opioid medication if needed. The device will remain in use until the subjects are able to breathe without the ventilator.

Conditions

Interventions

TypeNameDescription
DEVICEON-Q bupivicaine administrationcontinuous subcutaneous bupivicaine drip
DRUGIV opioid administrationPatient controlled analgesia with IV narcotics

Timeline

Start date
2009-02-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2009-04-13
Last updated
2013-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00880529. Inclusion in this directory is not an endorsement.